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New analytic methods that permit absolute CD4 and CD8 T-cell determinations to be performed entirely on
the flow cytometer have the potential for improving assay precision and accuracy. In a multisite trial, we
compared two different single-platform assay methods with a predicate two-color assay in which the absolute
lymphocyte count was derived by conventional hematology. A two-color method employing lymphocyte light
scatter gating and Beckman Coulter Flow-Count fluorospheres for absolute counting produced within-labo-
ratory precision equivalent to that of the two-color predicate method, as measured by coefficient of variation
of replicate measurements. The fully automated Beckman Coulter tetraONE System four-color assay employ-
ing CD45 lymphocyte gating, automated analysis, and absolute counting by fluorospheres resulted in a small
but significant improvement in the within-laboratory precision of CD4 and CD8 cell counts and percentages
suggesting that the CD45 lymphocyte gating and automated analysis might have contributed to the improved
performance. Both the two-color method employing Flow-Count fluorospheres and the four-color tetraONE
System provided significant and substantial improvements in between-laboratory precision of absolute counts.
In some laboratories, absolute counts obtained by the single-platform methods showed small but consistent
differences relative to the predicate method. Comparison of each laboratory’s absolute counts with the
five-laboratory median value suggested that these differences resulted from a bias in the absolute lymphocyte
count obtained from the hematology instrument in some laboratories. These results demonstrate the potential
for single-platform assay methods to improve within-laboratory and between-laboratory precision of CD4 and
CD8 T-cell determinations compared with conventional assay methods.
The progressive loss of CD41 T lymphocytes (CD4 T cells)
through virally mediated cell destruction is the predominant
pathophysiological manifestation of human immunodeficiency
virus type 1 (HIV-1) infection (15). Enumeration of this cell
subset provides an estimate of HIV disease progression (17). A
major component of the immune response to HIV-1 infection
is mediated by CD81 T lymphocytes (CD8 T cells) (6). CD8 T
cells capable of suppressing HIV-1 replication adopt an acti-
vation phenotype and appear in increased numbers in the
blood and other body compartments following infection (7,
19). Therefore, the CD4 and CD8 T cells in blood are fre-
quently quantified to assess immune competence and disease
stage in HIV-1-infected patients. Furthermore, changes in
CD4 T-cell numbers are an important estimate of the response
to antiretroviral therapy. The CD4 T-cell count remains the
most important immunologic surrogate marker of the efficacy
of new antiretroviral regimens used in clinical trial evaluations
(9). The accurate quantitation of these cells in blood is crucial
for providing clinical care to HIV-1-infected patients and for
the systematic evaluation of new therapeutic modalities. How-
ever, previous studies have identified substantial variability in
results between laboratories performing these assays (1, 5).
The currently recommended method for CD4 T-cell deter-
mination (2, 3) utilizes three independently derived values
from two different instruments: a white blood cell (WBC)
count and percent lymphocytes derived from a hematology
instrument, and percentage of CD4 or CD8 T cells derived
from a flow cytometer. A major disadvantage of this multiple-
platform assay method is that error in each independent mea-
surement is multiplied at each subsequent step in the calcula-
tion.
Recently, new analytic methods have emerged that permit
absolute CD4 and CD8 T-cell determinations to be performed
either using a single-determination, non-flow cytometry-based
assay (8, 10, 11) or entirely on the flow cytometer (14). In
the single-platform flow cytometry-based techniques, fluoro-
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spheres are added to the blood at a known concentration.
Absolute cell counts in each specimen can be calculated ratio-
metrically by simultaneously counting both fluorospheres and
the cells of interest (18). Other technological improvements,
including automated instrument setup, lymphocyte gating, and
cursor placement, could also improve assay performance. In
the present study, we have assessed the within-laboratory and
between-laboratory precision of two alternative assay methods:
a two-color method that uses Beckman Coulter Flow-Count
fluorospheres to determine absolute counts, and a four-color
method that uses the fully automated tetraONE System. The
precision obtained with these alternative methods was com-
pared with the precision obtained with a conventional multi-
ple-platform assay method. We also assessed the accuracy of
these two new assay methods by comparing the absolute counts
obtained with the single-platform methods and with the con-
ventional multiple-platform method.
MATERIALS AND METHODS
Sites. All five sites that participated in this study were clinical flow cytometry
laboratories that performed lymphocyte immunophenotyping for the AIDS Clin-
ical Trials Group and were certified by the National Institute of Allergy and
Infectious Disease (NIAID) Division of AIDS Flow Cytometry Certification
Program (2). All laboratories had extensive experience in performing clinical
immunophenotyping for CD41 and CD81 T lymphocytes by conventional meth-
ods but had no prior experience with the new, single-platform methods evaluated
in this study. Before participating in this study, workers in each laboratory
underwent a 2-day on-site training in the new methods by a representative from
Beckman Coulter. At each site, assays were performed by one laboratory tech-
nologist except for lab D, where study data were generated by three different
technologists.
Instrumentation. The hematology instruments used for determining absolute
lymphocyte counts varied at the five sites and included a Coulter STK-S, a
Technicon H2, a Sysmex HST430, and an Abbott CellDyn 3500 at labs A and D,
B, C, and E, respectively. All laboratories performed flow cytometric analyses
with the Beckman Coulter EPICS XL flow cytometer (Beckman Coulter, Miami,
Fla.) using System II software and tetraONE System (version 1.0; Beckman
Coulter). Specimen preparation was performed on the Multi-Q-Prep worksta-
tion (Beckman Coulter). All pipetting was performed with a positive-displace-
ment Eppendorf Repeater pipetter (Brinkmann Instruments, Westbury, N.Y.).
Reagents. All reagents were provided by Beckman Coulter and used as rec-
ommended by the manufacturer.
Specimens. To measure within-laboratory precision, specimens were obtained
locally at each site from HIV-1-infected donors after informed consent was
obtained (hereafter referred to as local specimens). Laboratories were requested
to obtain specimens from seven donors with CD4 T cell counts of ,200 cells/ml
and seven with CD4 T cell counts of .200 cells/ml. Blood was drawn directly into
evacuated blood collection tubes containing EDTA and delivered to the labo-
ratory within 1 h. To measure between-laboratory precision, specimens were
obtained from HIV-1-infected donors by a central contractor (FAST Systems,
Inc., Gaithersburg, Md.). We attempted to obtain an equivalent number of
specimens representing the following three CD4 T-cell count strata: ,200 cells,
200 to 500 cells, and .500 cells. Blood was drawn directly into evacuated blood
collection tubes containing EDTA and then shipped at ambient temperature by
overnight courier service to each site (hereafter referred to as central speci-
mens). Confirmation of HIV-1 infection status was made by routine clinical
serology. The number of specimens analyzed in the comparison of within-labo-
ratory precision and between-laboratory precision studies was chosen to provide
an 80% power to detect shifts in percent coefficient of variation (%CV) or in
median CD4 or CD8 T-cell counts. These calculations were based on variability
estimates from a previous study (11).
Flow cytometric immunophenotyping for CD41 and CD81 T lymphocytes. All
local and central blood specimens were analyzed by three different methods
(summarized in Table 1). Each site performed these assays in one of three
different orders for the entire study.
(i) Predicate method. Absolute lymphocyte counts were determined as the
product of the WBC count and percent lymphocyte differential as measured by
the hematology instruments. Flow cytometer alignment, calibration, and spectral
compensation were performed according to each individual laboratory’s operat-
ing procedure. For specimen preparation, 100 ml of EDTA-anticoagulated blood
was incubated with premixed antibodies for 20 min and erythrocytes were lysed
with the ImmunoPrep reagent system (Beckman Coulter) on a Multi-Q-Prep
work station and analyzed within 6 h of lysis. The percentage of lymphocytes
expressing CD3 and CD4 or CD3 and CD8 was determined according to the
published guidelines for Flow Cytometric Immunophenotyping (2, 3). A lym-
phocyte light scatter gate (scattergate) was manually drawn on a dot plot of side
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to meet or exceed the guidelines’ target percent purity (.85%) and percent
recovery (.90%) using CD45 and CD14 expression (2, 3). The percentages of
CD31 CD41 and CD31 CD81 lymphocytes within the total lymphocyte light
scattergate were determined by using the two-color antibody combinations de-
scribed in Table 1 and adjusted for purity by dividing the measured subset
percentage by the percent purity. Absolute CD31 CD41 and CD31 CD81
lymphocyte counts (herein referred to as CD4 T-cell counts and CD8 T-cell
counts, respectively) were calculated by multiplying the specific subset percent-
age by the absolute lymphocyte count.
(ii) Flow-count method. The percentages of CD31 CD41 and CD31 CD81
lymphocytes were determined by using a manually drawn lymphocyte scattergate
and two-color immunofluorescence as described for the predicate method above.
Immediately prior to analysis, 100 ml of Flow-Count fluorospheres (Beckman
Coulter) were added to each lysed specimen. Absolute CD4 and CD8 T-cell
counts were automatically determined by the System II software using the ratio
of CD31 CD41 or CD31 CD81 lymphocytes to fluorospheres counted using the
following formula: cells per microliter 5 [(cells counted)/(fluorospheres count-
ed)] 3 fluorospheres/microliter.
(iii) tetraONE method. The tetraONE System (Beckman Coulter) consists of
a fully automated software-reagent combination that performs CD4 and CD8
T-cell counts by four-color analysis on the EPICS XL flow cytometer. In this
integrated software-reagent system, instrument standardization and spectral
compensation are performed automatically by analysis of four tubes of bead
standards or fluorochrome-stained reference cells prior to specimen analysis. For
each specimen, 100 ml of EDTA-anticoagulated blood was incubated with 10 ml
of tetraCHROME reagent containing the four antibody-fluorochrome combina-
tions described in Table 1. Specimens were then lysed as described above on a
Multi-Q-Prep work station. Immediately prior to analysis, 100 ml of Flow-Count
fluorospheres was added to each tube. Tubes were placed into an autoloading
carousel, and sample acquisition and analysis were performed automatically by
the tetraONE System software. A lymphocyte gate was determined automatically
using CD45 fluorescence and side scatter parameters. The percentages of CD31
CD41 and CD31 CD81 lymphocytes within the lymphocyte gate were reported.
Absolute CD4 and CD8 T-cell counts were automatically calculated using the
ratio of cells to fluorospheres as described above for the Flow-Count method.
Data review and exclusion. All histograms from the hematology analyzers and
flow cytometers were reviewed by operators for consistent light scatter and
fluorescence patterns prior to reporting data. Data were considered unusable for
the following reasons: (i) inability to generate an absolute lymphocyte count on
the hematology instrument, (ii) absence of detectable fluorescence (e.g., no
antibody added), and (iii) incomplete or abnormal lysis of erythrocytes, as de-
termined by observing abnormal light scatter patterns or differences in CD3% of
.5 percentage points between tubes. Analyses that failed to yield usable results
for these reasons accounted for less than 1% of the total data collected. Data for
central specimens that were deemed unusable at one site were excluded from all
sites. Of 75 central specimens that arrived on time, 8 were excluded from analysis
at all sites for the reasons described above.
Within-laboratory precision. To compare the within-laboratory precision of
the three assay methods, each site attempted to obtain local specimens from 14
HIV-positive donors in which half of the specimens had a CD4 T-cell count of
.200 cells/ml and half had a CD4 T-cell count of ,200 cells/ml. A total of eight
tubes (5 ml each) of blood were drawn sequentially from each donor. Four tubes
were used for “fresh” analysis, where eight replicate analyses (two analyses for
each of four tubes) were performed by all three methods within 6 h of blood
collection. The remaining four tubes were held at ambient temperature over-
night, and the identical eight replicate analyses were performed by all three
methods. Analysis of “aged” specimens was performed 22 to 33 h after blood
collection.
Between-laboratory precision. Each site received identical amounts of 103
blood specimens obtained by a central contractor. Equivalent representation of
donors in the following CD4 T-cell count strata was attempted: ,200 cells/ml,
200 to 500 cells/ml, and .500 cells/ml. Each central specimen was analyzed at
each site by all three methods within 36 h of blood collection.
Accuracy of absolute counts. We calculated the differences in absolute counts
between each single-platform method and the predicate method to determine
the extent of agreement between the new and predicate methods using the
central specimens that had been assayed at each site. Differences between new
and predicate methods were plotted for each laboratory. We also attempted to
assess whether differences between new and predicate methods in individual
laboratories were due to assay biases in the predicate or the single-platform
methods. For each specimen, we calculated the difference between the individual
laboratory’s absolute CD4 or CD8 T-cell count and the median absolute count
from all five laboratories. Deviations from the median value were plotted for
each laboratory by method.
Statistical analyses. Variability was determined by using the %CV. Determi-
nation of significant differences between the variability of the Flow-Count
method and the predicate method and between the tetraONE method and the
predicate method were based on the Wilcoxon rank sum test. This test was
applied to the %CVs of CD4 and CD8 T-cell counts and the %CVs of CD4 and
CD8 T-cell percentages for each specimen (between laboratories for central
specimens and among replicates for local specimens). Comparisons of the dif-
ferences in absolute counts (and percentages) between the Flow-Count method
and the predicate method and between the tetraONE method and the predicate
method were based on the Wilcoxon rank sum test applied to the CD4 and CD8
T-cell counts (and percentages) for each specimen at each laboratory, stratifying
by donor in the case of local specimens. The same test was used to compare the
differences in absolute counts (and percentages) between specimens analyzed
fresh and the same specimens analyzed after 22 to 33 h (using the same analytical
method). A Bonferroni correction for multiple testing (k 5 2, statistical signif-
icance defined as P , 0.025) was used to adjust for comparing both the Flow-
Count and tetraONE methods with the same predicate method results.
RESULTS
Description of data. (i) Local specimens. All laboratories
analyzed specimens from $14 local donors, and a description
of these specimens is shown in Table 2. Despite a protocol
requesting that each laboratory recruit an equivalent number
of donors with CD4 T-cell counts of .200 cells/ml and ,200
cells/ml, two laboratories (A and D) obtained fewer than seven
specimens from donors having ,200 CD4 T cells/ml.
(ii) Central specimens. Of 103 central specimens shipped by
the central contractor, 87 were received by all sites within 33 h
of collection. Of the 87 specimens received on time, usable
data were generated by all sites on 67 specimens comparing the
predicate and Flow-Count methods and on 71 specimens com-
paring the predicate and tetraONE methods (Table 3). All
three CD4 T-cell strata were represented in these specimens.
However, the CD4 .500 cells/ml stratum was somewhat un-
derrepresented (,20% of all specimens).
Within-laboratory precision. (i) Flow-Count method versus
predicate method. Eight replicates of each local specimen were
analyzed by both the predicate and Flow-Count methods
within 6 h of specimen collection. The precision of absolute
CD4 and CD8 T-cell counts and percentages was determined
for each method by calculating the %CV from the replicate
measurements of each specimen. As shown in Table 4, the
median %CV for absolute CD4 and CD8 T-cell counts ob-
tained by the Flow-Count method were usually similar or lower
TABLE 2. Summary of statistics for local specimens analyzeda
Laboratory







CD4 CD8 CD4 CD8 CD4 CD8
All 71 242 (16) 799 (56) 29 100 (8) 764 (59) 42 359 (22) 821 (51)
A 14 292 (15) 1,042 (59) 3 174 (9) 1,083 (66) 11 309 (16) 993 (58)
B 15 240 (17) 639 (55) 7 113 (9) 623 (59) 8 337 (24) 639 (44)
C 14 174 (16) 649 (54) 7 92 (8) 806 (56) 7 319 (21) 617 (43)
D 14 252 (18) 888 (53) 5 101 (8) 746 (57) 9 395 (20) 980 (48)
E 14 238 (16) 781 (58) 7 52 (4) 629 (62) 7 538 (22) 837 (53)
a The median number of cells per microliter (median percentage) was determined by the predicate method 22 to 33 h after collection.
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than the %CV for results obtained by the predicate method
but did not differ significantly. As expected, the median %CV
for percentage of CD4 and CD8 T cells obtained by the Flow-
Count and predicate methods (Table 5) were nearly identical,
since both of these methods calculated CD4 and CD8 T-cell
percentages using a two-color assay with a manually drawn
lymphocyte light scatter gate. These results suggest that the use
of Flow-Count fluorospheres for absolute cell counting re-
sulted in overall within-laboratory precision that was equiva-
lent to that obtained using the predicate method.
There was considerable variation between laboratories in
the relative precision achieved by these two methods. In three
laboratories, the median %CV was lower for the Flow-Count
method than for the predicate method. In the other two lab-
oratories, the median %CV was lower for the predicate
method (Fig. 1A). However, differences in precision between
methods were never statistically significant. Of note, the two
laboratories whose CD4 and CD8 T-cell counts were less pre-
cise by the Flow-Count than by the predicate method also had
the lowest %CV by the predicate method (Fig. 1A).
(ii) tetraONE method versus predicate method. The preci-
sion in CD4 and CD8 T-cell absolute counts and percentages
obtained by the four-color tetraONE method was compared
with that of the predicate method in the manner described
above. As shown in Table 4, the %CV for both absolute CD4
and CD8 T-cell counts was significantly lower for values ob-
tained by the tetraONE method than for those obtained by the
predicate method. This improved precision for both CD4 and
CD8 T-cell subsets occurred predominantly in specimens with
CD4 T cell counts of ,200 cells/ml. Within this stratum, %CVs
decreased overall by 1 to 2%. While statistically significant, the
improvement in precision was relatively small. The tetraONE
method, which employed an automated CD45 lymphocyte gat-
ing strategy, also resulted in significantly lower %CV for CD4
and CD8 T-cell percentages (predominantly in the ,200 CD4
T-cell count stratum) compared with the predicate method
(Table 5). Thus, use of the tetraONE method resulted in a
small but significant improvement in the within-laboratory pre-
cision of CD4 and CD8 T-cell counts and percentages over the
predicate method.
Striking differences were observed in the relative precision
that individual laboratories obtained by the tetraONE and
predicate methods. Of the five participating laboratories, three
showed a lower median %CV with the tetraONE method than
with the predicate method for absolute CD4 or CD8 T-cell
counts (Fig. 1B). However, in two laboratories, the tetraONE
method resulted in a higher median %CV than the predicate
method. The two laboratories that obtained poorer perfor-
mance with the tetraONE method were the same laboratories
in which poorer performance occurred with the Flow-Count
method.
(iii) Fresh versus aged specimens. The effect of overnight
aging of specimens on assay precision and on absolute CD4
and CD8 T-cell counts was also assessed with the local speci-
mens. To measure the effect on precision, we determined the
%CV of the absolute CD4 and CD8 T-cell counts for speci-
mens analyzed within 6 h of drawing and compared that with
the %CV observed for the same specimens analyzed between
24 and 33 h after drawing (all CD4 strata combined). There
were no significant differences in assay precision (i.e., %CV)
when fresh and aged specimens were analyzed by either the
predicate or the Flow-Count method. Aging also had no effect
on the precision of CD8 T-cell counts obtained by the tetra-
ONE method. The %CV of absolute CD4 T-cell counts ob-
tained using the tetraONE method was significantly greater for
aged specimens than for fresh specimens. However, the me-
dian increase in %CV was small (,1%), and despite this in-
crease, the median %CV for CD4 T-cell counts on aged spec-
imens analyzed by the tetraONE method was still smaller than
the median %CV for fresh specimens analyzed by the predi-
cate or Flow-Count method (data not shown).
The overnight aging of specimens resulted in very small but
statistically significant changes in absolute CD4 and CD8 T-
cell counts, as measured by both the Flow-Count and tetra-
ONE methods (median change in CD4 and CD8 T-cell counts
TABLE 5. Comparison of within-laboratory precision of CD4 and













CD4 All 4.1 4.5 (0.530) 3.7 (0.001)
,200 6.5 6.0 (0.863) 4.3 (0.001)
.200 3.4 3.3 (0.240) 3.0 (0.225)
CD8 All 1.9 1.8 (0.515) 1.8 (0.268)
,200 1.8 2.0 (0.697) 1.5 (0.016)
.200 1.9 1.8 (0.565) 2.0 (0.565)
a See Table 4, footnote a.
TABLE 3. Summary statistics for central specimens analyzed




Flow-Count All 67 265 (20) 734 (56)
,200 25 141 (14) 561 (56)
200–500 33 319 (22) 834 (58)
.500 9 600 (33) 911 (42)
tetraONE All 71 279 (20) 756 (56)
,200 25 142 (14) 572 (56)
200–500 34 320 (22) 851 (58)
.500 12 611 (34) 895 (41)
a Median cells per microliter (median percentage) by the predicate method for
all laboratories combined.
TABLE 4. Comparison of within-laboratory precision of absolute
CD4 and CD8 T-cell counts for predicate method versus Flow-
Count and tetraONE methodsa
T cells CD4stratum







CD4 All 5.8 5.6 (0.421) 4.8 (0.002)
,200 8.9 7.4 (0.619) 4.6 (0.002)
.200 5.1 5.2 (0.617) 4.9 (0.288)
CD8 All 6.0 5.4 (0.076) 5.5 (0.017)
,200 7.6 5.3 (0.066) 5.8 (0.004)
.200 5.4 5.5 (0.599) 5.2 (0.516)
a %CVs were calculated from eight replicates of each specimen at 6 h. Rep-
licate analyses were performed by each method. %CVs in Flow-Count and
tetraONE methods were compared with %CV from the predicate method as
described in Materials and Methods. A P value of ,0.025 was considered sig-
nificant.
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for the Flow-Count method was 27 and 218 cells/ml, respec-
tively, and for the tetraONE method it was 24 and 19 cells/ml,
respectively). Aging had no effect on absolute CD4 T-cell
counts determined by the predicate method. However, by the
predicate method, aged specimens yielded significantly higher
CD8 T-cell counts (median change, 118 cells/ml) (data not
shown).
Between-laboratory precision. (i) Flow-Count method ver-
sus predicate method. The between-laboratory precision in
absolute CD4 and CD8 T-cell counts was compared between
the Flow-Count and predicate methods using central speci-
mens that were analyzed at all five laboratories. The %CV was
calculated from the values obtained in the five laboratories for
each specimen by the different assay methods. Analysis of
absolute CD4 and CD8 T-cell counts by the Flow-Count
method resulted in significantly improved between-laboratory
precision (Table 6). Compared with the predicate method, the
Flow-Count method reduced between-laboratory %CV for
absolute CD4 and CD8 T-cell counts by approximately 7%.
There was a tendency toward greater decreases in %CV
among specimens with lower CD4 counts. Significant reduc-
tions in between-laboratory %CV were observed for CD4 and
CD8 T-cell counts on specimens in the ,200 and 200 to 500
strata (Table 6). The %CV of the CD4 and CD8 T-cell per-
centages did not vary significantly between these two assay
methods (data not shown).
(ii) tetraONE method versus predicate method. Similar
analyses were performed to compare the between-laboratory
precision in absolute CD4 and CD8 T-cell counts by the tetra-
ONE method and the predicate method. Compared with the
predicate method, the tetraONE method also resulted in a
significant reduction of between-laboratory %CV (Table 7).
The magnitude of this reduction was similar to that observed in
the Flow-Count method. The reduction in %CV occurred
across all CD4 strata (Table 7). The %CVs of CD4 T-cell
percentages did not differ significantly between the two meth-
ods. However, the %CVs of CD8 T-cell percentages were
slightly but significantly higher for tetraONE results than for
predicate results (median difference in %CV, 11.9%) (data
not shown).
Accuracy of single-platform methods. The accuracy of the
single-platform methods was determined by comparing results
from the new methods with those obtained using the predicate
method. Using results from the central specimens, subset per-
FIG. 1. Comparison of within-laboratory precision in absolute CD4 and CD8 T-cell counts between predicate method and single-platform methods by laboratory.
Median %CVs are illustrated for each method from eight replicates of $14 specimens. (A) Flow-Count method versus predicate method; (B) tetraONE method versus
predicate method. p, significantly different from predicate method, P , 0.025.
TABLE 6. Comparison of between-laboratory precision in absolute
T-cell counts for predicate method versus Flow-Count methoda
T cells CD4 stratum(cells/ml)
Median %CV (P vs predicate method)
Predicate method Flow-Count method
CD4 All 18.2 10.8 (0.000)
,200 19.5 12.0 (0.000)
200–500 16.7 9.4 (0.007)
.500 18.8 12.1 (0.055)
CD8 All 16.9 10.1 (0.000)
,200 18.1 10.8 (0.000)
200–500 15.5 7.9 (0.002)
.500 17.2 10.8 (0.098)
a %CVs were calculated from the same specimens analyzed by both methods
in all five laboratories. %CV by the predicate method was compared with %CV
by the test method as described in Materials and Methods. A P value of ,0.025
was considered significant.
TABLE 7. Comparison of between-laboratory precision in absolute
T-cell counts for predicate method versus tetraONE methoda
T cells CD4 stratum(cells/ml)
Median %CV (P vs predicate method)
Predicate method tetraONE method
CD4 All 18.2 9.6 (0.000)
,200 19.5 9.6 (0.001)
200–500 16.6 10.8 (0.001)
.500 19.8 9.5 (0.009)
CD8 All 16.9 12.1 (0.000)
,200 18.1 11.3 (0.000)
200–500 15.4 14.8 (0.356)
.500 18.8 10.8 (0.052)
a See Table 6, footnote a.
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centages or absolute counts from the predicate method were
subtracted from results derived by either the Flow-Count or
tetraONE method to determine the direction and magnitude
of the differences. Overall, there was good agreement between
CD4 and CD8 T-cell percentages derived by the predicate
method and those obtained using either the Flow-Count or
tetraONE method. Median CD4 and CD8 T-cell percentages
varied by less than 2 percentage points between predicate and
Flow-Count or tetraONE except for laboratory D, in which the
tetraONE method yielded a median CD8 T-cell percentage
that was 4 percentage points lower than the median CD8 T-cell
percentage from the predicate method (data not shown).
The differences in absolute counts between the predicate
and single-platform methods by laboratory are shown in Fig. 2.
Four laboratories (A, B, D, and E) produced absolute counts
using the Flow-Count method that were slightly but consis-
tently lower that the absolute counts derived by their predicate
method (median absolute difference: CD4, 218 to 247 cells/ml
[Fig. 2A]; CD8, 248 to 2112 cells/ml [Fig. 2B]). The remaining
laboratory (C) produced results using the Flow-Count method
that were consistently higher than those derived by the predi-
cate method (median absolute difference: CD4, 17; CD8,
142) (Fig. 2A and B). Interestingly, the identical pattern of
differences was observed in each laboratory when absolute
counts derived by their predicate method and tetraONE
method were compared (Fig. 2C and D). The same laborato-
ries (A, B, D, and E) produced results using the tetraONE
method that were lower than their predicate method results
(median absolute difference: CD4, 214 to 236 cells/ml; CD8,
230 to 2196 cells/ml). The same remaining laboratory (C)
produced higher absolute counts by the tetraONE method
than with the predicate method (median absolute difference:
CD4, 119; CD8, 122).
Source of difference in absolute counts between predicate
and single-platform methods. The magnitude and direction of
the differences we observed in absolute counts between either
the Flow-Count or tetraONE method and the predicate
method were consistent within each laboratory. However, it
was unclear whether discrepancies in absolute counts between
the predicate and single-platform methods occurred because
one of the methods consistently yielded higher or lower results
in an individual laboratory. In an attempt to determine the
source of this bias, we compared the absolute count generated
by each laboratory with the median absolute counts from all
five laboratories for each method. This analysis assumed
that the five-laboratory median absolute count would be
closer to the actual absolute count than any individual mea-
surement.
Figure 3 illustrates the differences observed when the five-
laboratory median value was subtracted from the predicate
value (x axis), and the tetraONE value (y axis) for absolute
CD4 T-cell counts measured in each laboratory. Laboratory B,
which showed good agreement between absolute counts de-
rived by the tetraONE and predicate methods (Fig. 2C), also
showed good agreement between CD4 T-cell counts and the
five-laboratory median CD4 T-cell count obtained by both
assay methods (Fig. 3B). The median difference between this
laboratory’s values and the five-laboratory median values for
the predicate and Flow-Count methods was 0 and 0, respec-
tively. Laboratory C, which produced higher absolute CD4
T-cell counts by tetraONE than by their predicate method
(Fig. 2C), showed a bias toward underestimation of CD4 T-cell
count by their predicate method (median difference, 241 cells)
compared with the five-laboratory median. However, this lab-
oratory’s results by tetraONE were in good agreement with the
five-laboratory tetraONE median values (median difference, 0
cells) (Fig. 3C). This suggested that the bias in absolute counts
from laboratory C was largely due to underestimation by the
predicate method. In contrast, laboratory E produced lower
CD4 T-cell counts by the tetraONE method than by their
predicate method (Fig. 2C). A comparison of this laboratory’s
values with the five-laboratory median values suggested that
the difference in this laboratory was due to an overestimation
of CD4 T-cell count by the predicate method. Laboratory E’s
results from the tetraONE method agreed well with the five-
laboratory median values (predicate median difference, 15
cells; tetraONE difference, 0 cells) (Fig. 3E). The results from
laboratories A and D were less clear cut. It appeared that bias
in both the tetraONE and predicate methods might have con-
tributed to the overall difference in CD4 T-cell counts gener-
ated by these two methods. Although only data from CD4
T-cell counts by the tetraONE method are illustrated, the same
trend was observed for absolute CD8 T-cell counts generated
by the tetraONE method and for all absolute counts generated
by the Flow-Count method.
FIG. 2. Absolute differences in CD4 and CD8 T-cell counts between single-
platform and predicate methods. (A and B) Flow-Count method minus predicate
for CD4 (A) and CD8 (B); (C and D) tetraONE method minus predicate for
CD4 (C) and CD8 (D). Box indicates median and interquartile range (25th and
75th percentiles); upper and lower lines indicate 90th and 10th percentiles,
respectively.
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DISCUSSION
The single-platform flow cytometric methodologies for CD4
and CD8 T-cell determinations represent simple and efficient
modifications in clinical lymphocyte subset enumeration. The
results of this study confirm that use of Flow-Count fluoro-
spheres for absolute counting in a two-color, light scatter-gated
assay can provide within-laboratory precision that is equivalent
to a predicate, two-color, scatter-gated assay in which absolute
lymphocyte counts are derived by conventional hematology.
The tetraONE System has automated CD45 lymphocyte gating
and analysis and uses fluorosphere-derived absolute counting.
This method provided a small but significant improvement in
within-laboratory precision for both percentages and absolute
counts compared with the two-color predicate method. The
evaluation of these two single-platform assays suggests that
two features of the tetraONE System, automated CD45 lym-
phocyte gating and automated analysis, contribute more to
improving within-laboratory precision than the use of fluoro-
spheres for absolute counting.
More strikingly, use of Flow-Count fluorospheres in either a
two-color, light scatter-gated assay or the four-color, auto-
mated tetraONE System resulted in significant and substantial
improvement in between-laboratory precision. Both single-
platform assay methods decreased between-laboratory %CV
by nearly half compared with the predicate method. The with-
in-laboratory and between-laboratory precision that we ob-
served using a conventional multiple-platform method was
nearly identical to the precision observed in other multisite
studies that analyzed similar specimens (1, 11, 14).
Despite an overall improvement in assay precision, the per-
formance of individual laboratories varied considerably. Only
three of the five participating laboratories, when examined
individually, showed a significant improvement in within-labo-
ratory precision using the tetraONE method. The same trend
among laboratories, although not statistically significant, was
observed for the Flow-Count method. The two laboratories
that failed to improve their precision were the same laborato-
ries that enrolled fewer local donors in the ,200 CD4 cells
stratum. The single-platform methods resulted in greater im-
provement in precision in specimens with lower CD4 T-cell
counts. Therefore, this different distribution of CD4 T-cell
counts in the specimens analyzed by these two laboratories
may have contributed to their apparent difference in perfor-
mance using the single-platform methods. The single-platform
methodologies also required greater pipetting precision than
that needed to perform the predicate methodologies because
accurate results rely on a precise 1:1 volume ratio of blood and
fluorosphere suspension. Furthermore, the single-platform as-
say methods represented new procedures at all participating
sites, while these laboratories were all very experienced in the
predicate assay. These facts may have also served to favor the
predicate method at some sites.
We also analyzed the differences in absolute counts (and
percentages) obtained by the new and predicate assays as an
estimate of accuracy of the single-platform methods and to
understand how the single-platform assay methods would im-
pact the absolute CD4 and CD8 T-cell counts (and percent-
ages) currently reported in individual laboratories. Overall,
there was good agreement between the new and predicate
methods in CD4 and CD8 T-cell percentage values. However,
individual laboratories observed small but consistent differ-
ences in absolute counts between the predicate and single-
FIG. 3. Source of absolute CD4 T-cell count bias in individual laboratories. The absolute CD4 T-cell count generated in each laboratory by the predicate or
tetraONE method was subtracted from the five-laboratory median value by that method to determine whether method biases occurred in individual laboratories. A
through E are laboratory designations. The shaded region indicates the interquartile range (25th and 75th percentiles) of these differences.
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platform assays. These differences could have resulted from
assay bias in either the predicate or single-platform methods.
To address this question, we used the results from central
specimens analyzed by all laboratories. We concluded that the
absolute count bias in at least two laboratories occurred in the
predicate method. The bias in these laboratories was probably
introduced by the lymphocyte counts from the automated he-
matology analyzer because the CD4 and CD8 T-cell percent-
ages did not vary by assay method. However, the absolute
counts derived by the predicate method showed more devia-
tion from the median than the absolute counts derived by the
single-platform methods. Consistent with our observation, oth-
ers have identified the lymphocyte count derived from the
hematology instrument as the predominant source of CD4
count bias (13; R. Gelman and C. Wilkening, submitted for
publication). In two other laboratories, both the predicate and
single-platform method results differed from the median re-
sults of all laboratories. Of note, these were the same labora-
tories that were unable to show improved within-laboratory
precision using the new methods.
The comparison of absolute counts (and percentages) be-
tween predicate and new methods was performed using
shipped, central specimens. Consensus guidelines recommend
that the automated hematology for obtaining the absolute lym-
phocyte count be performed within 6 h of drawing (2, 3). With
some automated hematology analyzers, substantial changes in
cell counts can occur after EDTA-anticoagulated blood is aged
for periods longer than 12 to 24 h (12, 16). Therefore, the use
of 1-day-old central specimens might have created a slight
disadvantage for the predicate method.
This multisite evaluation of Flow-Count fluorospheres and
the tetraONE System in a clinical setting provides assurance
that these assay methods are precise and reliable alternatives
to multiple-platform CD4 and CD8 T-cell determinations.
These methods provided not only modest improvement in
within-laboratory precision but substantial improvement in be-
tween-laboratory agreement. Therefore, these single-platform
methods have considerable potential to improve data consis-
tency within multicenter trials. However, the impact of imple-
menting a single-platform method on assay precision and ac-
curacy within individual laboratories will depend on biases
inherent in current methods and the skill of testing personnel.
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ADDENDUM
After this study was completed, Beckman Coulter modified
the algorithm used by the tetraONE System to automatically
gate lymphocytes. In the current version (version 2.0 and sub-
sequent releases), the tetraONE System utilizes forward light
scatter, CD45 fluorescence, and side light scatter parameters
for lymphocyte gating. In the present study, only CD45 fluo-
rescence and side light scatter parameters were used for this
gating.
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